Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenichi Hosonuma

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The American Journal of Gastroenterology|July 7, 2015
Response to Licinio et alKen Sato, Kenichi Hosonuma, Motoyasu Kusano, et al.
Hepatology International|August 12, 2009
Small-cell carcinoma of the extrahepatic bile duct: a case report and review of the literatureKenichi Hosonuma, Ken Sato, Manabu Honma, et al.
Gastroenterology Research and Practice|March 28, 2013
Incidence, mortality, and predictive factors of hepatocellular carcinoma in primary biliary cirrhosisKenichi Hosonuma, Ken Sato, Masatoshi Yanagisawa, et al.
Digestive Diseases and Sciences|December 17, 2009
Familial clustering and genetic background of primary biliary cirrhosis in JapanMasatoshi Yanagisawa, Hitoshi Takagi, Hitomi Takahashi, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 27, 2005
[Hepatic metastasis from choroidal malignant melanoma developing 15 years after enucleation]Kenichi Hosonuma, Ken Sato, Hitoshi Takagi, et al.
The American Journal of Gastroenterology|March 4, 2015
A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemiaKenichi Hosonuma, Ken Sato, Yuichi Yamazaki, et al.
The Tohoku Journal of Experimental Medicine|January 17, 2017
Combination Therapy with Ombitasvir/Paritaprevir/Ritonavir for Dialysis Patients Infected with Hepatitis C Virus: A Prospective Multi-Institutional StudyKen Sato, Kenichi Hosonuma, Yuichi Yamazaki, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2019
Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Retrospective StudyTakeshi Hatanaka, Satoru Kakizaki, Daisuke Uehara, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The American Journal of Gastroenterology|July 7, 2015
Response to Licinio et alKen Sato, Kenichi Hosonuma, Motoyasu Kusano, et al.
Hepatology International|August 12, 2009
Small-cell carcinoma of the extrahepatic bile duct: a case report and review of the literatureKenichi Hosonuma, Ken Sato, Manabu Honma, et al.
Gastroenterology Research and Practice|March 28, 2013
Incidence, mortality, and predictive factors of hepatocellular carcinoma in primary biliary cirrhosisKenichi Hosonuma, Ken Sato, Masatoshi Yanagisawa, et al.
Digestive Diseases and Sciences|December 17, 2009
Familial clustering and genetic background of primary biliary cirrhosis in JapanMasatoshi Yanagisawa, Hitoshi Takagi, Hitomi Takahashi, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 27, 2005
[Hepatic metastasis from choroidal malignant melanoma developing 15 years after enucleation]Kenichi Hosonuma, Ken Sato, Hitoshi Takagi, et al.
The American Journal of Gastroenterology|March 4, 2015
A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemiaKenichi Hosonuma, Ken Sato, Yuichi Yamazaki, et al.
The Tohoku Journal of Experimental Medicine|January 17, 2017
Combination Therapy with Ombitasvir/Paritaprevir/Ritonavir for Dialysis Patients Infected with Hepatitis C Virus: A Prospective Multi-Institutional StudyKen Sato, Kenichi Hosonuma, Yuichi Yamazaki, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2019
Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Retrospective StudyTakeshi Hatanaka, Satoru Kakizaki, Daisuke Uehara, et al.
Pageof 1